Building and Crossing the Translational Bridge: 2016 Alopecia Areata Research Summit Highlights

Dory Kranz; Abby Ellison; Natasha A Mesinkovska; Angela M Christiano; Maria K Hordinsky; John E Harris

doi:10.1016/j.jisp.2017.10.004

Building and Crossing the Translational Bridge: 2016 Alopecia Areata Research Summit Highlights

J Investig Dermatol Symp Proc. 2018 Jan;19(1):S3-S8. doi: 10.1016/j.jisp.2017.10.004.

Authors

Dory Kranz¹, Abby Ellison², Natasha A Mesinkovska³, Angela M Christiano⁴, Maria K Hordinsky⁵, John E Harris⁶

Affiliations

¹ National Alopecia Areata Foundation, San Rafael, California, USA. Electronic address: dory@naaf.org.
² National Alopecia Areata Foundation, San Rafael, California, USA.
³ National Alopecia Areata Foundation, San Rafael, California, USA; Department of Dermatology, University of California, Irvine, California, USA.
⁴ Columbia University Medical Center, New York, New York, USA.
⁵ Department of Dermatology, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
⁶ Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

PMID: 29273102
DOI: 10.1016/j.jisp.2017.10.004

Abstract

Alopecia areata (AA) is a common autoimmune skin disease that results in the loss of hair on the scalp and elsewhere on the body and affects over 146 million people worldwide at some point in their lives. Founded in 1981, the National Alopecia Areata Foundation is a nonprofit organization that supports research to find a cure or acceptable treatment for AA, supports those with the disease, and educates the public about AA. The National Alopecia Areata Foundation conducts research summits every 2 years to review progress and create new directions in its funded and promoted research. The Foundation brings together scientists from all disciplines to get a broad and varied perspective. These AA research summits are part of the Foundation's main strategic initiative, the AA Treatment Development Program, to enhance the understanding of AA and accelerate progress toward a viable treatment.

Publication types

Congress
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Alopecia Areata / etiology
Alopecia Areata / therapy*
Animals
Disease Models, Animal
Foundations
Humans
Translational Research, Biomedical / trends

Grants and funding

R13 AR071266/AR/NIAMS NIH HHS/United States